InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Sharp John P, Chief Financial Officer. Director active across 2 companies, notably PhaseBio Pharmaceuticals Inc. In total, 11 reports have been logged. The latest transaction was disclosed on 20 May 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations11 total
€3,8816,026 shares@ €0.6444.7% of flow
Common Stock
SEC:0001169245-22-000074:0·
€3,5662,017 shares@ €1.76819.2% of flow
Common Stock
SEC:0001169245-21-000127·
€3,5662,017 shares@ €1.76814.4% of flow
Common Stock
SEC:0001169245-21-000127:0·
€10,8817,500 shares@ €1.450828.0% of flow
Common Stock
SEC:0001169245-21-000103·
€10,8817,500 shares@ €1.450813.3% of flow
Common Stock
SEC:0001169245-21-000103:0·
€10,6157,500 shares@ €1.415427.3% of flow
Common Stock
SEC:0001169245-21-000087·
€10,6157,500 shares@ €1.415413.0% of flow
Common Stock
SEC:0001169245-21-000087:0·
€10,6157,500 shares@ €1.415427.3% of flow
Common Stock
SEC:0001169245-21-000071·
€10,6157,500 shares@ €1.415413.0% of flow
Common Stock
SEC:0001169245-21-000071:0·
€3,2501,419 shares@ €2.29038.3% of flow
Common Stock
SEC:0001169245-21-000047·
€3,2501,419 shares@ €2.29034.0% of flow
Common Stock
SEC:0001169245-21-000047:0·
11 of 11 declarations
About Sharp John P
John P. Sharp is the Chief Financial Officer at PhaseBio Pharmaceuticals Inc. He is responsible for the financial management of the company, including financial planning and analysis. His expertise is crucial in supporting the growth and sustainability of PhaseBio.
